Therefore, we analyzed hepatic expression of Htr2a and Htr2b by immunostaining and quantitative real-time PCR in these mouse models to determine whether the expression of these receptors was associated with modification of 5-HT expression in NAFLD mice (Fig. 3). This evidence concerns the gene HTR5A and metabolic dysfunction-associated steatotic liver disease.